First dose: full dose, then according to kidneys
| - ATB - | - Dose - |
| Meropenem | 2 g first dose, then 1–2 g VI Q8h |
| - Site - | ATB |
| Urosepsis | ESBL coverage: meropenem (works for Enterococcus also) |
| Pneumonia | |
| - Species - | |
| MRSA | |
| - Severity - | |
| - Scared (risk tolerance) - | |
| - Special cases - | |
| Splenectomy | |
| Neutropenia | |
Hydrocortisone 50 mg IV Q6
| Time dependent | fT > MIC | frequent/prolonged/continuous infusion | beta-lactams (fT > MIC 40–100 %), lincosamides (clindamycin, lincomycin) |
| (Peak) Concentration dependent | Cmax > MIC | high doses with extended-interval | aminoglycosides, fluorochinolones |
| Concentration dependent with time-dependence (mixed) | AUC/MIC | vancomycin, cotrimoxazol, linezolid, macrolides, tetracyclines, daptomycin, polymyxins |
ATB I.V.:
Enterálně ATB:
Antivirotika:
Antimykotika IV:
Antimykotika NEBUL:
ATB intranasálně: